7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with prostaglandin d2 in 1 studies
Studies (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Trials (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Recent Studies (post-2010) (7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid) | Studies (prostaglandin d2) | Trials (prostaglandin d2) | Recent Studies (post-2010) (prostaglandin d2) |
---|---|---|---|---|---|
39 | 15 | 14 | 3,454 | 78 | 751 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aritake, K; Buslon, VS; Eguchi, N; French, SW; Grujic, S; Kanaoka, Y; Kwong, AM; Lin, HJ; Materi, AM; Park, JM; Salido, E; Tippin, BL; Urade, Y | 1 |
1 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and prostaglandin d2
Article | Year |
---|---|
Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice.
Topics: Adenomatous Polyposis Coli; Animals; Dinoprost; Female; Hematopoietic System; Intramolecular Oxidoreductases; Lipocalins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Prostaglandin D2; Prostaglandins | 2007 |